In 2023, the number of scientific publications among the world's 10% top-cited in pulmonary and respiratory medicine in China was 120.3. The forecast for 2024 through 2028 shows a consistent year-on-year increase, with values progressing from 131.6 to 176.84. This reflects percentage increases of 8.6% from 2024 to 2025 and 7.9% from 2025 to 2026, continuing the upward movement with similar rates each subsequent year.

The five-year compound annual growth rate (CAGR) indicates a steady expansion in this domain, contributing to China's global research influence. Looking forward, key trends to monitor include:

Potential policy changes in China affecting research funding and prioritization.
The impact of international collaborations on research output.
Technological advancements in data collection and analysis that could enhance research quality.